Current and historical daily PE Ratio for Beijing Science Sun Pharmaceutical Co Ltd (
) from 2015 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Science Sun Pharmaceutical stock (SZSE:300485) PE ratio as of Jun 08 2024 is 0.
More Details
Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) PE Ratio (TTM) Chart
Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Beijing Science Sun Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | At Loss | 2024-04-01 | At Loss |
| 2024-06-07 | At Loss | 2024-03-29 | At Loss |
| 2024-06-06 | At Loss | 2024-03-28 | At Loss |
| 2024-06-05 | At Loss | 2024-03-27 | 39.0 |
| 2024-06-04 | At Loss | 2024-03-26 | 39.4 |
| 2024-06-03 | At Loss | 2024-03-25 | 39.3 |
| 2024-05-31 | At Loss | 2024-03-22 | 40.7 |
| 2024-05-30 | At Loss | 2024-03-21 | 41.8 |
| 2024-05-29 | At Loss | 2024-03-20 | 42.1 |
| 2024-05-28 | At Loss | 2024-03-19 | 42.1 |
| 2024-05-27 | At Loss | 2024-03-18 | 42.9 |
| 2024-05-24 | At Loss | 2024-03-15 | 41.1 |
| 2024-05-23 | At Loss | 2024-03-14 | 40.6 |
| 2024-05-22 | At Loss | 2024-03-13 | 40.4 |
| 2024-05-21 | At Loss | 2024-03-12 | 40.9 |
| 2024-05-20 | At Loss | 2024-03-11 | 39.6 |
| 2024-05-17 | At Loss | 2024-03-08 | 38.6 |
| 2024-05-16 | At Loss | 2024-03-07 | 38.4 |
| 2024-05-15 | At Loss | 2024-03-06 | 38.8 |
| 2024-05-14 | At Loss | 2024-03-05 | 39.0 |
| 2024-05-13 | At Loss | 2024-03-04 | 39.9 |
| 2024-05-10 | At Loss | 2024-03-01 | 39.3 |
| 2024-05-09 | At Loss | 2024-02-29 | 39.0 |
| 2024-05-08 | At Loss | 2024-02-28 | 38.0 |
| 2024-05-07 | At Loss | 2024-02-27 | 40.5 |
| 2024-05-06 | At Loss | 2024-02-26 | 39.8 |
| 2024-04-30 | At Loss | 2024-02-23 | 39.1 |
| 2024-04-29 | At Loss | 2024-02-22 | 38.3 |
| 2024-04-26 | At Loss | 2024-02-21 | 38.0 |
| 2024-04-25 | At Loss | 2024-02-20 | 37.6 |
| 2024-04-24 | At Loss | 2024-02-19 | 36.9 |
| 2024-04-23 | At Loss | 2024-02-08 | 35.9 |
| 2024-04-22 | At Loss | 2024-02-07 | 33.4 |
| 2024-04-19 | At Loss | 2024-02-06 | 34.3 |
| 2024-04-18 | At Loss | 2024-02-05 | 32.8 |
| 2024-04-17 | At Loss | 2024-02-02 | 36.8 |
| 2024-04-16 | At Loss | 2024-02-01 | 38.3 |
| 2024-04-15 | At Loss | 2024-01-31 | 39.0 |
| 2024-04-12 | At Loss | 2024-01-30 | 41.7 |
| 2024-04-11 | At Loss | 2024-01-29 | 43.2 |
| 2024-04-10 | At Loss | 2024-01-26 | 44.6 |
| 2024-04-09 | At Loss | 2024-01-25 | 44.5 |
| 2024-04-08 | At Loss | 2024-01-24 | 42.7 |
| 2024-04-03 | At Loss | 2024-01-23 | 41.9 |
| 2024-04-02 | At Loss | 2024-01-22 | 42.1 |
Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Beijing Science Sun Pharmaceutical Co Ltd
ISIN : CNE100002110
Share Class Description:
SZSE:300485: Class ACompare
Compare
Traded in other countries / regions
300485.China IPO Date
2015-06-26Description
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers